Literature DB >> 34534070

Home portable monitoring for the diagnosis of sleep-disordered breathing in adolescents and adults with neuromuscular disorders: not yet ready for prime time.

Mahadevappa Hunasikatti1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34534070      PMCID： PMC8726363          DOI： 10.5664/jcsm.9652

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  5 in total

Review 1.  Pediatric Home Sleep Apnea Testing: Slowly Getting There!

Authors:  Hui-Leng Tan; Leila Kheirandish-Gozal; David Gozal
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

2.  Ready for Primetime? Home Sleep Apnea Tests for Children.

Authors:  Rakesh Bhattacharjee
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

3.  American Academy of Sleep Medicine Position Paper for the Use of a Home Sleep Apnea Test for the Diagnosis of OSA in Children.

Authors:  Valerie Kirk; Julie Baughn; Lynn D'Andrea; Norman Friedman; Anjalee Galion; Susan Garetz; Fauziya Hassan; Joanna Wrede; Christopher G Harrod; Raman K Malhotra
Journal:  J Clin Sleep Med       Date:  2017-10-15       Impact factor: 4.062

Review 4.  Sleep-Disordered Breathing in Duchenne Muscular Dystrophy: An Assessment of the Literature.

Authors:  Romy Hoque
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

5.  Validation of home portable monitoring for the diagnosis of sleep-disordered breathing in adolescents and adults with neuromuscular disorders.

Authors:  Jean N Westenberg; Basil J Petrof; Francine Noel; David Zielinski; Evelyn Constantin; Maryam Oskoui; Marta Kaminska
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324
  5 in total
  1 in total

1.  Diagnosing sleep-disordered breathing in neuromuscular diseases in 2021.

Authors:  Marta Kaminska; David Zielinski; Basil J Petrof; Jean N Westenberg; Evelyn Constantin
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.